生命科学
在生命科学行业取得成功不仅关乎研发,还关乎战略和执行。随着技术在全球范围内以极快的速度颠覆行业,Goodwin 不仅在生命科学领域的丰富经验,而且与我们的技术、医疗保健、房地产和私募股权律师合作,使我们的团队非常适合解决无论未来如何。

Our globally recognized Life Sciences practice is uniquely positioned to partner with innovators and investors operating in a fast-moving, tech-driven environment.
With more than 230 dedicated life sciences lawyers across all major sector hubs in the US, Europe, and Asia, we work with life sciences companies throughout the corporate life cycle — from startup to maturity — as well as investors, banks, and others in the life sciences ecosystem.
We understand the unique challenges life science companies face in securing funding, licensing and safeguarding intellectual property (IP), establishing partnerships, bringing new products to market, opening new revenue streams, and protecting existing product lines. We take a multidisciplinary approach to address clients’ challenges, drawing on our deep expertise across industries — such as technology, healthcare, real estate, and private equity — as well as the full spectrum of relevant practices.
Our comprehensive life sciences coverage includes:
- Complex financing and M&A transactions
- Capital market transactions advising issuers, sponsors, underwriters, and investors
- Life sciences collaborations and licensing
- Life sciences regulatory and compliance diligence and advisory services
- FDA litigation
- Patent prosecution, counseling, due diligence, and portfolio strategy
- IP litigation, including brand and generic patent, trade secret, trademark, and copyright litigation
- Products litigation
- Corporate governance
- High-stakes litigation
- Data, privacy, and cybersecurity
- Antitrust services for life sciences companies
- Employment
- AI in Life Sciences
- Tax and other areas
Connect with our Life Sciences team and let us know how we can help.
IPO Readiness at Goodwin

Resilience & Innovation: Goodwin Life Sciences in 2024

Securities Litigation Against Life Sciences Companies 2024 Year in Review

Antitrust & Competition Life Sciences Year in Review 2024

Contacts
- Mitchell S. Bloom

Mitchell S. Bloom
合伙人Chair, Life Sciences - Kingsley L. Taft

Kingsley L. Taft
合伙人Co-Chair, Life Sciences - Stuart M. Cable

Stuart M. Cable
Vice Chair & Global Head of M&A